EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Combination of immune checkpoint inhibitors and radiotherapy in locally advanced esophagogastric junction adenocarcinoma: A review

Romina Abyaneh iD, Reza Ghalehtaki iD, Nina N Sanford iD

Cancer · 2024-12 · 130 (23) · 4040-4051

DOI: 10.1002/cncr.35561 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer, online erschienen am 19.09.2024. Verfasst von Romina Abyaneh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Oncology Research Center, Cancer Research Institute, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Esophagogastric Junction, Esophageal Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 56 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Esophagogastric adenocarcinoma (EGJ‐AC) poses a significant global health burden, characterized by high incidence rates and poor prognosis. Despite advancements in treatment modalities, including surgery, chemotherapy, and radiation therapy (RT), locally advanced EGJ‐AC management remains challenging. Various preclinical and clinical studies have provided insights into the synergistic effects of combining immune checkpoint inhibitors (ICIs) with RT, further supporting the combination therapy in EGJ‐AC. Immunotherapy, particularly ICIs, has emerged as a promising therapeutic approach in various malignancies, including EGJ‐AC. This narrative review aims to critically examine the rationale behind combining ICIs with standard treatment modalities, including RT or chemoradiotherapy, in the preoperative setting for locally advanced EGJ‐AC. A comprehensive literature search identified eight phase 2 randomized clinical trials evaluating the safety profile and oncologic outcomes of adding ICI agents to neoadjuvant chemoradiotherapy in this population. The results of enrolled trials show that the combination of ICIs with standard treatment modalities is a promising approach for improving survival and pathological response in patients with locally advanced EGJ‐AC. This combination treatment was associated with mostly grade 1–2 immune‐related toxicities, indicating its safety and tolerability. There were higher rates of complete or major pathologic responses compared to historical controls. Further studies, including large‐scale randomized controlled trials, are needed to address remaining questions regarding the efficacy, safety, and long‐term outcomes of combination therapy in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsEsophagogastric JunctionEsophageal NeoplasmsAdenocarcinomaHumansStomach NeoplasmsCombined Modality TherapyNeoadjuvant TherapyRandomized Controlled Trials as TopicChemoradiotherapyClinical Trials, Phase II as Topic

Stichwörter der Autor:innen

chemoradiotherapycombination therapyesophagogastric adenocarcinomaimmune checkpoint inhibitorsimmunotherapyradiotherapy

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Radiation Oncology Research Center, Cancer Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Radiation Oncology, Cancer Institute, IKHC, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

ORCID-Profile: Romina Abyaneh, Reza Ghalehtaki, Nina N Sanford

Zitieren

APA

Abyaneh, R., Ghalehtaki, R., & Sanford, N. N. (2024). Combination of immune checkpoint inhibitors and radiotherapy in locally advanced esophagogastric junction adenocarcinoma: A review. Cancer, 130(23), 4040-4051. https://doi.org/10.1002/cncr.35561

Vancouver

Abyaneh R, Ghalehtaki R, Sanford NN. Combination of immune checkpoint inhibitors and radiotherapy in locally advanced esophagogastric junction adenocarcinoma: A review. Cancer. 2024;130(23):4040-4051. doi:10.1002/cncr.35561

BibTeX
@article{Abyaneh2024,
  author = {Abyaneh, Romina and Ghalehtaki, Reza and Sanford, Nina N},
  title = {Combination of immune checkpoint inhibitors and radiotherapy in locally advanced esophagogastric junction adenocarcinoma: A review},
  journal = {Cancer},
  year = {2024},
  volume = {130},
  number = {23},
  pages = {4040--4051},
  doi = {10.1002/cncr.35561}
}
Kostenlos starten →